Tags : Severe Malaria

Amivas’s Artesunate Receives the US FDA’s Approval for Treatment of

Vartika Singh May 27, 2020

Shots: Amivas’ Artesunate for Injection (110 mg) is a powder and solvent for solution US FDA approved and is targeted for initial treatment of severe malaria in adult and pediatric […]readmore

Tags : Severe Malaria

Amivas’s Artesunate Receives the US FDA’s Approval for Treatment of

Latest Posts

PharmaShots Weekly Snapshots (November 15 – 19, 2021)

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Company

Tags : Severe Malaria

Amivas’s Artesunate Receives the US FDA’s Approval for Treatment of

Latest Posts

PharmaShots Weekly Snapshots (November 15 – 19, 2021)

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Categories

Related Topics

Company